ACT-AD Executive Director Testifies at Key FDA Meeting

ACT-AD’s Executive Director Cynthia Bens was invited by FDA to participate in a July 15 meeting on reauthorization of Prescription Drug User Fee Act (PDUFA) program. At the meeting, Bens offered several suggestions for PDUFA’s renewal, including the continuation of Patient Focused Drug Development (PFDD) meetings. Bens noted, “After such positive experiences with ACT-AD, we were fierce supporters of the Patient Focused Drug Development (PFDD) Initiative during PDUFA V…a priority of ours in PDUFA VI will be funding for the continuation of FDA-led PFDD meetings.” You can read her entire testimony here.

File Attachments